Sosei Appoints David Chiswell as Non-Executive Chairman
Sosei Co. Ltd. announced the appointment of Dr. David Chiswell as Non-Executive Chairman.
David Chiswell was a founder and, from 1996 to 2002, the CEO of Cambridge Antibody Technology (CAT). Currently David is Chairman of the UK's BioIndustry Association (BIA). In addition, he is Chairman of Arrow Therapeutics Ltd and a non-executive director of Arakis Ltd. David is also an advisor to a number of private equity funds including Nomura Phase 4 Ventures. His previous experience was gained with Amersham International as well as within research posts at various institutions including the Medical Research Council, UCLA and the Imperial Cancer Research Fund.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.